106 related articles for article (PubMed ID: 9075499)
1. Stability of amphotericin B 0.05 and 0.5 mg/mL in 20% fat emulsion.
Owens D; Fleming RA; Restino MS; Cruz JM; Hurd DD
Am J Health Syst Pharm; 1997 Mar; 54(6):683-6. PubMed ID: 9075499
[No Abstract] [Full Text] [Related]
2. Amphotericin B intralipid formulation: stability and particle size.
Ranchère JY; Latour JF; Fuhrmann C; Lagallarde C; Loreuil F
J Antimicrob Chemother; 1996 Jun; 37(6):1165-9. PubMed ID: 8836819
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B formulated in a lipid emulsion.
Cleary JD
Ann Pharmacother; 1996 Apr; 30(4):409-12. PubMed ID: 8729899
[No Abstract] [Full Text] [Related]
4. Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.
Lopez RM; Ayestaran A; Pou L; Montoro JB; Hernandez M; Caragol I
Am J Health Syst Pharm; 1996 Nov; 53(22):2724-7. PubMed ID: 8931814
[TBL] [Abstract][Full Text] [Related]
5. [Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results].
Blancard A; Monges P; Lacarelle B; Denis JP; Bongrand MC; Ragon CH; Gouin F
Pathol Biol (Paris); 1996 May; 44(5):384-8. PubMed ID: 8758481
[TBL] [Abstract][Full Text] [Related]
6. Precipitation of amphotericin B from i.v. fat emulsion.
Heide PE
Am J Health Syst Pharm; 1997 Jun; 54(12):1449. PubMed ID: 9194992
[No Abstract] [Full Text] [Related]
7. Comment: compatibility of amphotericin B with lipid emulsions.
Montoro JB; López RM; Pou L
Ann Pharmacother; 1996 Dec; 30(12):1501. PubMed ID: 8968472
[No Abstract] [Full Text] [Related]
8. Amphotericin B does not mix with fat emulsion.
Trissel LA
Am J Health Syst Pharm; 1995 Jul; 52(13):1463-4. PubMed ID: 7671046
[No Abstract] [Full Text] [Related]
9. Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions.
Schmidt S; Müller RH
Int J Pharm; 2003 Mar; 254(1):3-5. PubMed ID: 12615399
[TBL] [Abstract][Full Text] [Related]
10. Stereostructure of amphotericin A.
Sowiński P; Bieszczad T; Pawlak J; Borowski E
J Antibiot (Tokyo); 1996 Dec; 49(12):1232-5. PubMed ID: 9031669
[No Abstract] [Full Text] [Related]
11. Comments concerning 'The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis'.
Washington C; Davis SS
Biopharm Drug Dispos; 1995 Aug; 16(6):529-31. PubMed ID: 7579034
[No Abstract] [Full Text] [Related]
12. Conformational analysis of amphotericin B molecule.
Silberstein AYa ; Smirnov SL
Membr Cell Biol; 1997; 10(5):553-63. PubMed ID: 9225259
[TBL] [Abstract][Full Text] [Related]
13. Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar.
Thakur CP
Trans R Soc Trop Med Hyg; 1994; 88(6):698-9. PubMed ID: 7886778
[No Abstract] [Full Text] [Related]
14. Antifungal activity against Candida albicans of starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate films.
Cossu A; Wang MS; Chaudhari A; Nitin N
Int J Pharm; 2015 Sep; 493(1-2):233-42. PubMed ID: 26231107
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Intralipid emulsions of amphotericin B.
Sievers TM; Kubak BM; Wong-Beringer A
J Antimicrob Chemother; 1996 Sep; 38(3):333-47. PubMed ID: 8889711
[TBL] [Abstract][Full Text] [Related]
16. Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS.
Manfredi R; Chiodo F
Pharmacotherapy; 1998; 18(5):1087-92. PubMed ID: 9758320
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B in fat emulsion.
Kintzel PE
Am J Health Syst Pharm; 1996 Nov; 53(22):2701. PubMed ID: 8931810
[No Abstract] [Full Text] [Related]
18. Structure and toxicity of amphotericin B/triglyceride emulsion formulations.
Lance MR; Washington C; Davis SS
J Antimicrob Chemother; 1995 Jul; 36(1):119-28. PubMed ID: 8537259
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based formulations of amphotericin B.
Swenson CE; Bolcsak LE; Perkins WR; Janoff AS
J Antimicrob Chemother; 1995 May; 35(5):709-13. PubMed ID: 7592188
[No Abstract] [Full Text] [Related]
20. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
